With the global pandemic firmly in the rearview mirror, life sciences companies are looking at key macro- and micro-economic drivers to guide their future growth. While the list of trends with wide-ranging global impact is broad, in this year, life sciences enterprises are paying particular attention to those more disruptive trends.
In our 2024 Global Life Sciences Sector Outlook report, we emphasise on these key trends such as increasing pricing pressures, geopolitical environment, changes in US regulations and the acceleration of Generative AI (GenAI) adoption to expedite drug discovery, cost reduction and revenue uplift.
With geopolitical, economic and regulatory landscapes still proving uncertain, life sciences will likely need to continue relying on innovation, agility and collaboration as they build on their strong commitment to bettering the lives of patients.
Review or download previous life sciences sector outlooks.
Interested in the trends and Issue affecting healthcare providers, health plans and government health organisations? Explore our global healthcare sector outlook.